hydroxyurea has been researched along with Ovarian Neoplasms in 12 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The overall response rate in the 18 cervical cancer patients was 89% (78% complete, 11% partial)." | 2.69 | Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies. ( Fleming, G; Mundt, AJ; Quiet, C; Rotmensch, J; Waggoner, S, 1999) |
| "In cultured ovarian cancer cells, 5-LOX metabolites were increased under hypoxic conditons." | 1.42 | Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration. ( Fan, B; Gao, W; Li, B; Li, M; Liu, H; Qu, X; Shao, Q; Wang, Q; Wen, Z; Xie, Q; Yang, Y; Yu, J; Zhao, F, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, L | 1 |
| Zhao, Y | 1 |
| Quan, C | 1 |
| Ji, W | 1 |
| Zhu, J | 1 |
| Huang, Y | 1 |
| Guan, R | 1 |
| Sun, D | 1 |
| Jin, Y | 1 |
| Meng, X | 1 |
| Zhang, C | 1 |
| Yu, Y | 1 |
| Bai, J | 1 |
| Sun, W | 1 |
| Fu, S | 1 |
| Wen, Z | 1 |
| Liu, H | 1 |
| Li, M | 1 |
| Li, B | 1 |
| Gao, W | 1 |
| Shao, Q | 1 |
| Fan, B | 1 |
| Zhao, F | 1 |
| Wang, Q | 1 |
| Xie, Q | 1 |
| Yang, Y | 1 |
| Yu, J | 1 |
| Qu, X | 1 |
| Yilmaz, B | 1 |
| Teksoz, S | 1 |
| Kilcar, AY | 1 |
| Ucar, E | 1 |
| Ichedef, C | 1 |
| Medine, EI | 1 |
| Ari, K | 1 |
| Rupniak, HT | 1 |
| Whelan, RD | 1 |
| Hill, BT | 1 |
| Strobel, T | 1 |
| Swanson, L | 1 |
| Korsmeyer, S | 1 |
| Cannistra, SA | 1 |
| Mundt, AJ | 1 |
| Rotmensch, J | 1 |
| Waggoner, S | 1 |
| Quiet, C | 1 |
| Fleming, G | 1 |
| Raymond, E | 1 |
| Faivre, S | 1 |
| Weiss, G | 1 |
| McGill, J | 1 |
| Davidson, K | 1 |
| Izbicka, E | 1 |
| Kuhn, JG | 1 |
| Allred, C | 1 |
| Clark, GM | 1 |
| Von Hoff, DD | 1 |
| Mathews, CK | 1 |
| Wollner, N | 1 |
| Lieberman, P | 1 |
| Exelby, P | 1 |
| D'angio, G | 1 |
| Burchenal, J | 1 |
| Fang, S | 1 |
| Murphy, ML | 1 |
| Brady, LW | 1 |
| Chiu, CS | 1 |
| Chan, AK | 1 |
| Wright, JA | 1 |
| Ariel, IM | 1 |
1 review available for hydroxyurea and Ovarian Neoplasms
| Article | Year |
|---|---|
Combined modality therapy of gynecologic cancer.
Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Evaluation Studies as Topic; Female; Genit | 1975 |
2 trials available for hydroxyurea and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 1999 |
Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosomes, Human, Pai | 2001 |
9 other studies available for hydroxyurea and Ovarian Neoplasms
| Article | Year |
|---|---|
Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; DNA Damage; DNA, Neoplas | 2013 |
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration.
Topics: Animals; Arachidonate 5-Lipoxygenase; Cell Line; Cell Line, Tumor; Chemotaxis, Leukocyte; Disease Mo | 2015 |
In Vitro/In Vivo Evaluation of Radiolabeled [(99m)Tc(CO)3](+)-Hydroxyurea and Fluorescein Isothiocyanate-Hydroxyurea.
Topics: Animals; Breast Neoplasms; Dextrans; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Hydrox | 2016 |
Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro.
Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxo | 1983 |
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Carboplatin; C | 1996 |
Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Culture M | 1975 |
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosp | 1975 |
Inhibition of mammalian ribonucleotide reductase by cis-diamminedichloroplatinum(II).
Topics: Animals; Cell Division; Cisplatin; Colonic Neoplasms; Drug Resistance; Escherichia coli; Female; Hum | 1992 |
Anticancer therapy with hydrea: comparative study of daily vs. intermittent oral dosage.
Topics: Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Dose-Response Relationship, Dr | 1974 |